Page last updated: 2024-11-11

stearidonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators
FloraRankFlora DefinitionFamilyFamily Definition
LithospermumgenusA plant genus of the family BORAGINACEAE. Members contain lithospermans and lithospermic acid.[MeSH]BoraginaceaeThe Borage plant family is in the class Magnoliopsida, subclass Asteridae, order Lamiales. It is characterized by hairy foliage, usually alternate and simple; flowers are funnel-shaped or tubular. Some of the species contain PYRROLIZIDINE ALKALOIDS.[MeSH]
Lithospermum officinalespecies[no description available]BoraginaceaeThe Borage plant family is in the class Magnoliopsida, subclass Asteridae, order Lamiales. It is characterized by hairy foliage, usually alternate and simple; flowers are funnel-shaped or tubular. Some of the species contain PYRROLIZIDINE ALKALOIDS.[MeSH]

Cross-References

ID SourceID
PubMed CID5312508
CHEMBL ID484430
CHEBI ID32389
SCHEMBL ID29226
MeSH IDM0173865

Synonyms (35)

Synonym
20290-75-9
stearidonic acid ,
(6z,9z,12z,15z)-octadecatetraenoic acid
CHEBI:32389 ,
(6z,9z,12z,15z)-octadeca-6,9,12,15-tetraenoic acid
6z,9z,12z,15z-octadecatetraenoic acid
LMFA01030357
moroctic acid
morotic acid
fa 18:4
CHEMBL484430
unii-p4cek3495o
p4cek3495o ,
all-cis-6,9,12,15-octadecatetraenoic acid
moroctic acid (c18:4 n3)
.delta.6,9,12,15-octadecatetraenoic acid
stearidonic acid [who-dd]
stearidonic acid [mi]
111174-40-4
6,9,12,15-octadecatetraenoic acid, (6z,9z,12z,15z)-
6cis stearidonic acid
SCHEMBL29226
HMS3649J17
stearidonic acid c18:4
6,9,12,15-octadecatetraenoate
stearidonic acid, >=99%
DTXSID20920493
SR-01000946667-1
sr-01000946667
6(z),9(z),12(z),15(z)-octadecatetraenoic acid
Q2739877
fa(18:4(6z,9z,12z,15z))
AS-80602
6z, 9z, 12z, 15z- octadecatetraenoic acid
AKOS040735398

Research Excerpts

Overview

Stearidonic acid (SDA) is a plant-based n-3 polyunsaturated fatty acid with multiple biological activities. It is a Delta6-unsaturated C18 omega-3 fatty acid present in a few plant species. SDA is a metabolic precursor of EPA that can be provided by SDA-enhanced soybean oil.

ExcerptReferenceRelevance
"Stearidonic acid (SDA) is a plant-based n-3 polyunsaturated fatty acid with multiple biological activities. "( Efficient Synthesis of Stearidonic Acid Enriched Triacylglycerol from Ahiflower Seed Oil via a Two-Step Enzyme Reaction.
Ju, C; Kim, BH; Kim, IH; Lee, YJ; Yoon, HS, 2022
)
2.47
"Stearidonic acid is a Delta6-unsaturated C18 omega-3 fatty acid present in a few plant species (mainly the Boraginaceae and Primulaceae) reflecting the general absence of Delta6-desaturation from higher plants."( The synthesis and accumulation of stearidonic acid in transgenic plants: a novel source of 'heart-healthy' omega-3 fatty acids.
Graham, IA; Haslam, RP; Larson, TR; Napier, JA; Ruiz-López, N; Sayanova, O; Venegas-Calerón, M, 2009
)
1.35
"Stearidonic acid (SDA) is a non-marine fatty acid that appears to be more readily converted to EPA in humans."( Stearidonic acid raises red blood cell membrane eicosapentaenoic acid.
Maki, KC; Rains, TM, 2012
)
2.54
"Stearidonic acid (SDA) is a metabolic precursor of EPA that can be provided by SDA-enhanced soybean oil."( Stearidonic acid-enhanced soybean oil: a plant-based source of (n-3) fatty acids for foods.
Harris, WS, 2012
)
2.54
"Stearidonic acid (SDA) is an intermediate fatty acid in the biosynthetic pathway from α-linolenic acid to VLC ω-3 PUFAs and the conversion from SDA is more efficient than from α-linolenic acid."( Stearidonic acid as a supplemental source of ω-3 polyunsaturated fatty acids to enhance status for improved human health.
Calder, PC; Jebb, SA; Walker, CG, 2013
)
2.55

Effects

ExcerptReferenceRelevance
"Stearidonic acid has been shown in animal and human studies to be more effective than its precursor, α-linolenic acid, in enriching membranes with eicosapentaenoic acid. "( Stearidonic acid as a 'pro-eicosapentaenoic acid'.
Harris, WS, 2012
)
3.26

Toxicity

ExcerptReferenceRelevance
" In a 28-day pilot study, rats were gavaged with SDA soybean oil at dosages up to 3g/kg body weight/day; no treatment-related adverse effects were observed."( Safety assessment of SDA soybean oil: results of a 28-day gavage study and a 90-day/one generation reproduction feeding study in rats.
Ahmed, G; Fleeman, T; Hammond, BG; Kirkpatrick, J; Lemen, JK; Miller, KD, 2008
)
0.35

Compound-Compound Interactions

ExcerptReferenceRelevance
" Highly purified stearidonic acid (SDA) was prepared successfully from echium oil via an enzymatic method combined with preparative high performance liquid chromatography."( Preparation of Highly Purified Stearidonic Acid from Echium Oil via an Enzymatic Method Combined with Preparative High Performance Liquid Chromatography.
Baik, JY; Kim, IH; Kim, NH; Oh, SW, 2015
)
1.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
Daphnia galeata metaboliteA Daphnia metabolite produced by the species Daphnia galeata.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
omega-3 fatty acidA family of polyunsaturated fatty acids that have in common a final carbon-carbon double bond in the omega-3 position, i.e., the third bond from the methyl end of the fatty acid.
long-chain fatty acidA fatty acid with a chain length ranging from C13 to C22.
octadecatetraenoic acidA polyunsaturated fatty acid whose structure contains double bonds at any four positions of an 18-carbon straight chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Alpha Linolenic Acid and Linoleic Acid Metabolism517
Omega-3 / omega-6 fatty acid synthesis038
Elongation of (very) long chain fatty acids345
Omega-3 and omega-6 unsaturated fatty acids biosynthesis pathway014

Bioassays (14)

Assay IDTitleYearJournalArticle
AID334497Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID334496Antibacterial activity against Salmonella Typhimurium NCIB 10248 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID399613Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 at 0.5 mg/disk by disk diffusion assay
AID334491Antibacterial activity against Bacillus cereus NCIB 3329 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID334492Antibacterial activity against Bacillus subtilis NCIB 3610 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID334498Antibacterial activity against Pseudomonas putida T-AQ 18/YF18 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID334494Antibacterial activity against Streptococcus faecalis NCIB 775 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID334493Antibacterial activity against Staphylococcus aureus T-AQ 49/YF29 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID334490Antibacterial activity against Bacillus stearothermophilus NCA 1518 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID399610Antimicrobial activity against Proteus vulgaris ATCC 13315 at 0.5 mg/disk by disk diffusion assay
AID399612Antimicrobial activity against Staphylococcus aureus ATCC 25923 at 0.5 mg/disk by disk diffusion assay
AID399609Antimicrobial activity against Escherichia coli ATCC 25922 at 0.5 mg/disk by disk diffusion assay
AID334495Antibacterial activity against Escherichia coli B74-1 after 24 hrs by disk diffusion assay1993Journal of natural products, Jul, Volume: 56, Issue:7
Dicranin, an antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium.
AID399611Antimicrobial activity against Salmonella Typhimurium ATCC 14028 at 0.5 mg/disk by disk diffusion assay
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (131)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.76)18.7374
1990's5 (3.82)18.2507
2000's32 (24.43)29.6817
2010's83 (63.36)24.3611
2020's10 (7.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.69 (24.57)
Research Supply Index4.98 (2.92)
Research Growth Index5.68 (4.65)
Search Engine Demand Index63.04 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials12 (9.02%)5.53%
Reviews16 (12.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other105 (78.95%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]